Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,951.60
(
0.00%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
103.24
(
2.55%
)
Bitcoin
68,458.99
(
-0.47%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: EZ2 post# 23164

Friday, 02/03/2006 3:51:35 PM

Friday, February 03, 2006 3:51:35 PM

Post# of 257295
One more point about RHEO: a sham rheopheresis procedure—which is what patients in the placebo arm of RHEO’s trial received—is not going to make someone read an eye chart better. Thus, the claim in RHEO’s PR that an unexpectedly good response in the placebo arm caused the trial’s demise is patently absurd.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today